Repare Therapeutics Inc

NASDAQ:RPTX   4:00:00 PM EDT
1.57
+0.07 (+4.67%)
6:08:54 PM EDT: $1.55 -0.02 (-1.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)67.34M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5 Million
Adjusted EPS-$0.56
See more estimates
10-Day MA$1.50
50-Day MA$1.41
200-Day MA$1.88
See more pivots

Repare Therapeutics Inc Stock, NASDAQ:RPTX

7171 Frederick-Banting, Suite 270, Saint-Laurent, Qu�©bec H4S 1Z9
Canada
Phone: +1.857.412.7018
Number of Employees: 129
http://www.reparerx.com

Description

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.